UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000007020
Receipt No. R000008231
Scientific Title Phase II study of Erlotinib in previously treated advanced non-small cell lung cancer patients with carcinomatous meningitis
Date of disclosure of the study information 2012/01/05
Last modified on 2016/12/01 11:54:35

No. Disposal Last modified on Item of update
1 Insert 2012/01/05 15:43:26
2 Update 2012/07/06 16:19:32 Last name of lead principal investigator
Last name of lead principal investigator
Institute
Institutions
3 Update 2012/08/10 09:03:00 Email1
4 Update 2012/08/13 09:53:15 Key exclusion criteria
5 Update 2013/01/07 13:22:47 Institutions
6 Update 2013/07/05 17:55:56 Last follow-up date
7 Update 2013/07/05 18:23:02 Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
TEL
Email
Organization
Institutions
8 Update 2013/10/18 13:55:04 Key exclusion criteria
Key exclusion criteria
9 Update 2013/10/18 13:57:29 Email
10 Update 2014/07/08 09:21:06 Division name
Division name
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Institutions
11 Update 2015/01/22 11:02:52 Key inclusion criteria
12 Update 2015/08/21 16:18:08 Recruitment status
13 Update 2015/08/21 16:28:29 Organization
Organization
14 Update 2015/08/21 16:29:47 Division name
15 Update 2016/05/25 09:36:52 Name of primary sponsor
Organization
16 Update 2016/12/01 11:54:35 Recruitment status


Contact us.